HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biden Nominates Anti-Trust Expert Khan To FTC

Executive Summary

President Biden nominates Lina Khan for one of two FTC commissioner seats he will fill. Khan currently is a Columbia Law associate professor, teaching and writing about antitrust law, infrastructure industries law and the antimonopoly tradition.

You may also be interested in...



FTC Chair’s Anti-Trust Focus Could Impact Pricing, Sales Across Consumer Packaged Goods Sectors

Health, beauty and wellness industry stakeholders believe Lina Khan’s appointment increases chances FTC will aggressively enforce against e-commerce giant Amazon. Agency movement alleging antitrust against Amazon could impact the pricing and sales of products online.

Pharma Mergers May Have Tougher Time Clearing FTC Under New Review Scheme

FTC is working with Canadian and European enforcement agencies to come up with new approach to merger reviews that could look at effects on innovation and companies' past conduct. FTC to review closed mergers to see if corrective action is necessary, FTC acting chair says.

FTC Shift Under Biden Administration Begins With Chairman Simons, Senior Staff Resigning

While expected following start of Biden administration, Simon’s resignation is “somewhat of a surprise” considering it will change the balance of power to the Democrats ahead of when his term would have been ended, says advertising law attorney Ivan Wasserman.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel